Brachytherapy
Volume 8, Issue 3 , Pages 269-272, July 2009

Point: Why choose pulsed-dose-rate brachytherapy for treating gynecologic cancers?

  • Susan E. Davidson

      Affiliations

    • Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom
    • Corresponding Author InformationCorresponding author. Department of Clinical Oncology, The Christie NHS Foundation Trust,Wilmslow Road, Withington , Manchester M20 4BX Tel: +44(0)161-446-3330; fax:+44-(0)161-446-8111.
    • ,
  • Jolyon H. Hendry

      Affiliations

    • Addlington, Cheshire, United Kingdom
    • ,
  • Catharine M. West

      Affiliations

    • Academic Department of Radiation Oncology, University of Manchester, United Kingdom

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1538-4721(09)00229-3

doi:10.1016/j.brachy.2009.06.004

Brachytherapy
Volume 8, Issue 3 , Pages 269-272, July 2009

Article Tools